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Background: Interpretation of cardiac troponin results in asymptomatic patients with chronic kidney disease (CKD) is controversial. Utilizing high 
sensitivity assays for troponin I (hsTnI) and T (hsTnT) we sought to determine their association with cardiovascular (CV) disease and renal function.
Methods: We prospectively recruited 148 CKD patients (age 63.2±11.8, 68.9% male, 58.1% Caucasian, estimated glomerular filtration rate [eGFR] 
34.3±11.2 mls/min/1.73m2 [range 9-59]) not on dialysis to have CV disease assessed by coronary calcium (CAC) by CT scan, and left ventricular 
mass index (LVMI) by echocardiography. hsTnI (Siemens Vista, lower limit 0.2 pg/mL) and hsTnT (Roche Elecsys, lower limit 3 pg/mL) were measured 
from frozen serum. Troponin levels were tested for correlation with eGFR, CAC and LVMI and adjusted for age.
Results: Median hsTnI level was 6.3 pg/mL (IQ 3.4-14.4, range 1.1-138.8) and hsTnT level was 17 pg/mL (IQ 11-31, range < 3-147). Median CAC 
score was 81 (IQ range (7-309) with 68.9% ≥ 10. Median LVMI was 84.5 g/m2 (IQ 73.2-98.6). The correlations of each assay with renal function 
and CV disease are shown in Table. Neither assay was predictive of CAC ≥ 10 once adjusted for age.
Conclusion: New hsTnI and hsTnT assays detect levels in almost all CKD patients. While hsTnT appears more influenced by renal function and 
chronic CV pathology than hsTnI, this influence is modest.
Correlation of high sensitive troponin assays with renal function and cardiovasuclar disease
Univariate Multivariate*
hsTnI hsTnT hsTnI hsTnT
eGFR R=0.151, p=0.068 R=0.272, p=0.0009 p>0.02 p=0.004
Coronary Calcium score R=0.186, p=0.024 R=0.206, p=0.012 p>0.2 p=0.1
Left Ventricular Mass Index R=0.147, p=0.075 R=0.229, p=0.005 p=0.075 p=0.005
* Adjusted for age
